MAGEA4 and non-small cell lung carcinoma: In conclusion, this is the first work to use reverse vaccinology approach in designing a multi-epitope vaccine targeting MAGEA3, MAGEA4, NY-ESO-1, and KK-LC1 in NSCLC.